Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Vitamin D3 Supplementation for Low-Risk Prostate Cancer
NCT01759771Phase 2Completed
- Sponsor
- VA Office of Research & Development
- Start
- Jan 2013
- Primary completion
- Oct 2018
- Modality
- Orthosteric Ligands, Metabolically Activated Prodrugs
- Countries
- 1
01
Overview
A Phase 2 trial of vitamin d in prostate cancer (PCa), sponsored by VA Office of Research & Development. Started Jan 2013; status: completed.
02
Drugs
vitamin d
03
Conditions
prostate cancer (PCa)
Beyond the preview
Go deeper on NCT01759771.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01759771.